Zobrazeno 1 - 10
of 181
pro vyhledávání: '"Inserra, G."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zanoli L., Tuttolomondo A., Inserra G., Cappello M., Granata A., Malatino L., Castellino P., Cottone S., Di Raimondo D., Fatuzzo P., Gaudio A., Geraci G., Lentini P., Mule G., Pellegriti A., Pinto A., Rapisarda F., Rizzo R., Riguccio G., Scrivo B., Torres D., Xourafa A.
Publikováno v:
Journal of hypertension. 38(10)
Background Patients with Crohn's disease have an increased aortic stiffness, a known cardiovascular risk factor. Anxiety, a key factor of the brain--gut axis in patients with Crohn's disease, is implicated in the pathogenesis and progression of the d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4727d5f167cd08ac153d1339c193a93c
https://pubmed.ncbi.nlm.nih.gov/32890277
https://pubmed.ncbi.nlm.nih.gov/32890277
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Orlando, A., Macaluso, F., Fries, W., Privitera, A., Cappello, M., Siringo, S., Inserra, G., Magnano, A., Di Mitri, R., Belluardo, N., Scarpulla, G., Magrì, G., Trovatello, N., Carroccio, A., Genova, S., Bertolami, C., Vassallo, R., Ventimiglia, M., Renna, S., Orlando, R., Rizzuto, G., Cottone, M.
Background: In the absence of head-to-head trials, there is an unmeet need to better understand the relative effectiveness of different biologics in inflammatory bowel disease (IBD). The Sicilian Network for Inflammatory Bowel Disease (SN-IBD) is a g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::021de99063e3f7a66b81d31bc229df9e
https://hdl.handle.net/10447/279359
https://hdl.handle.net/10447/279359
Autor:
Orlando A., Macaluso F. S., Fries W., Privitera A. C., Cappello M., Siringo S., Inserra G., Magnano A., Di Mitri R., Belluardo N., Scarpulla G., Magrì G., Trovatello N., Carroccio A., Genova S., Calandruccio G., Vassallo R., Romano C., Pellegrino S., Citrano M., Accomando S., Ventimiglia M., Renna S., Orlando R., Rizzuto G., Vinci E., Cottone M.
Background: The monitoring of appropriateness, costs, and clinical outcomes of biological therapy in inflammatory bowel disease (IBD) is a relevant need. We aimed to evaluate all these issues in Sicily through a web based network of all prescribing c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::446fb2bc730944ab5a63283393a6c87d
http://hdl.handle.net/10447/279357
http://hdl.handle.net/10447/279357
Autor:
Orlando A., Fries W., Privitera A., Cappello M., Siringo S., Inserra G., Magnano A., Di Mitri R., Belluardo N., Scarpulla G., Magrì G., Trovatello A., Carroccio A., Genova S., Calandruccio G., Vassallo R., Romano C, Magazzù G., Citrano M., Accomando S., Ventimiglia M., Renna S., Orlando R., Rizzuto G., Vinci E., Macaluso F. S., Cottone M.
Background and aim: The monitoring of appropriateness and costs of biological therapy in Inflammatory bowel disease (IBD) is a relevant need. We aimed to evaluate appropriateness, efficacy and safety of biological therapy in IBD in Sicily through a w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8bd5ec51ff66efb7f9d2dd301992f619
http://hdl.handle.net/10447/279361
http://hdl.handle.net/10447/279361
Autor:
Renna, S., Mocciaro, F., Ventimiglia, M., Macaluso, F., Orlando, R., Billeci, M., Cappello, M., Mendolaro, M., Privitera, A., Ferracane, C., Fries, W., Pisana, V., Magnano, A., Pluchino, D., Inserra, G., Scarpulla, G., Garufi, S., Carroccio, A., Siringo, S., Dimitri, R., Cottone, M., Orlando, A.
Introduction: Adalimumab (ADA) and golimumab (GOL) are effective in the induction and maintenance treatment of moderate-to-severe ulcerative colitis (UC). No comparable data between the 2 drugs are available up to now. Aims & Methods: We reported the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::383eb6fd471e3ece82699b0ac2792c21
http://hdl.handle.net/10447/279365
http://hdl.handle.net/10447/279365
Autor:
Orlando, A., Macaluso, F., Fries, W., Privitera, A., Cappello, M., Siringo, S., Inserra, G., Magnano, A., Di Mitri, R., Belluardo, N., Scarpulla, G., Magrì, G., Trovatello, A., Carroccio, A., Genova, S., Bertolami, C., Vassallo, R., Romano, C., Pellegrino, S., Citrano, M., Accomando, S., Ventimiglia, M., Renna, S., Orlando, R., Rizzuto, G., Vinci, E., Cottone, M.
Introduction: The monitoring of appropriateness, costs, and clinical outcomes of biological therapy in inflammatory bowel disease (IBD) is a relevant need. Aims & Methods: We aimed to evaluate all these issues in Sicily through a webbased network of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1949eb087a7c4f0838e8b66d1d786271
http://hdl.handle.net/10447/279363
http://hdl.handle.net/10447/279363